News
IGC-M3 targets the disease on four fronts, showing promise in cellular models - POTOMAC, MD / ACCESS Newswire / August 5, 2025 /IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback